WILMINGTON, Mass. (AP) — WILMINGTON, Mass. (AP) — Charles River Laboratories International Inc. (CRL) on Wednesday reported a loss of $215.7 million in its fourth quarter.
The Wilmington, Massachusetts-based company said it had a loss of $4.22 per share. Earnings, adjusted for non-recurring costs, were $2.66 per share.
The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $2.50 per share.
The medical research equipment and services provider posted revenue of $1 billion in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $975.3 million.
For the year, the company reported profit of $10.3 million, or 20 cents per share. Revenue was reported as $4.05 billion.
Charles River expects full-year earnings in the range of $9.10 to $9.60 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRL at https://www.zacks.com/ap/CRL
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。